- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Seattle Genetics Inc
+ Add to WatchlistSGEN:US
35.1000 USD 0.2500 0.71%As of 14:28:56 ET on 05/24/2013.
Company Profile for Seattle Genetics Inc (SGEN)
Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.
Contact Information
Seattle Genetics Inc
21823 30th Drive SE
Bothell, WA 98021
United States
Key Executives for Seattle Genetics Inc (SGEN)
| Clay B SiegallChairman/Pres/CEO/Co-Founder | Todd E SimpsonChief Financial Officer |
| Eric L DobmeierChief Operating Officer | Vaughn B HimesExec VP:Technical Ops |
| Chris BoernerSenior VP:Commercial |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page